• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: May 9-13, 2011

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

May 9-13, 2011
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs5/9/11- 5/13/11N/AN/AN/ANo Significant Meetings
John M. Taylor, III, J.D., Acting Principal Deputy Commissioner of Food and Drugs5/9/11- 5/13/11N/AN/AN/ANo Significant Meetings
Dara A. Corrigan, Associate Commissioner for Regulatory Affairs5/9/11- 5/13/11N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products5/9/11- 5/13/11N/AN/AN/ANo Significant Meetings
David Dorsey, J.D., Acting Deputy Commissioner for Policy, Planning, and Budget5/9/11Silver Spring, MDJeff Shuren, Joy Stevens, Charles Ganley, Libero Marzella, Marc Walton, Issam ZinehSan Francisco Metro Chamber;  Cary Adams (MedStart); Ruth Tesar (Northern CA PET Imaging); Paul Lambert (SARTA/EMED Tech)Medical Product Innovation
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine5/10/11Rockville, MDWilliam Flynn, Dave White, Kevin Greenlees, Jeffrey Ward, Phil Kijak, Nadine Steinberg, Cathy Beck, Nathan DotyCathy Knupp, Scott Brown, Greg Andrews, Heidi Chen, David Smith, Stephen Sutherland (Pfizer Animal Health)Overview of the drug approval process
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health5/9/11- 5/13/11N/AN/AN/ANo Significant Meetings
Michael M. Landa, Acting Director, Center for Food Safety and Applied Nutrition5/11/11College Park, MDMary Poos, Felicia Billingslea, Geraldine June, Blakeley Fitzpatrick, Felicia Hogue, Paula TrumboMichael Jacobson, Julie Greenstein (Center for Science in the Public Interest); Cecilia Richardson, Douglas Greenway (National  WIC Association); Kelly Brunell ,Yate Rudd (Center for Food Policy); Caroline Aponan (Boston University School of Medicine)Health Message on Soft Drinks Containing HFCR, Sugar and other Sweetners
Caroline Lewis, Acting Deputy Commissioner for Administration5/9/11- 5/13/11N/AN/AN/ANo Significant Meetings
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs5/9/11- 5/13/11N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research5/9/11- 5/13/11N/AN/AN/ANo Significant Meetings
Meghan Scott, Acting Associate Commissioner for External Affairs5/9/11- 5/13/11N/AN/AN/ANo Significant Meetings
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health5/9/11Silver Spring, MDSeveral CDRH Staff MembersSteven Oesterle and Luanne Pendy (Medtronic, Inc.)Medical Devices
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health5/10/11Silver Spring, MDNancy Stade, William Maisel and Susan RunnerSeveral representatives from the American Dental Association (ADA)Medical Devices
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health5/11/11Washington, DCWilliam Maisel, Christy Foreman, Telba Irony, Michelle McMurry-HeathSeveral representatives from the National Organization for Rare Disorders (NORD)Medical Devices
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research5/9/11- 5/13/11N/AN/AN/ANo Significant Meetings
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods5/9/11- 5/13/11N/AN/AN/ANo Significant Meetings
Ralph Tyler, J.D., Chief Counsel5/9/11- 5/13/11N/AN/AN/ANo Significant Meetings
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs5/9/11- 5/13/11N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research5/9/11New York, NYJulie ZawiszaLisa Richwine (Reuters))Thomson Reuters Annual Meeting
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research5/10/11Boston, MAN/ARichard Gliklich (Harvard Medical School); Richard Platt (Harvard Medical School)Post-Approval Summit